A three-week course of methazolamide therapy for chronic open-angle glaucoma resulted in marked leukopenia and thrombocytopenia. Prompt discontinuation of therapy resulted in complete recovery of white blood cell and platelet counts within five days. The recommendations for patients receiving carbonic anhydrase inhibitors for blood count control at six-month intervals are discussed.
Get full access to this article
View all access options for this article.
References
1.
FRAUNFELDERFT, MEYERSM, BAGBYGC, DREISMW. Hematologic reactions to carbonic anhydrase inhibitors. Am J Ophthalmol1985; 100: 79-81.
2.
KRIVOYN, BEN-ARIEHY, CARTERA, ALROYG. Methazolamide-induced hepatitis and pure RBC aplasia. Arch Intern Med1981; 141: 1299-300.
3.
WARBLINTP, POLLACKIP, LISSRA. Blood dyscrasias in 2 patients using methazolamide (Neptazane) for glaucoma. Ophthalmology1980; 87: 350-4.
